nonprofit logo

The Ovarian Cancer Institute Inc

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 582445245 ✦ Atlanta, GA ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is The Ovarian Cancer Institute Inc?

The Ovarian Cancer Institute Inc, situated in Atlanta, Georgia, is a committed nonprofit organization dedicated to advancing ovarian cancer research. Their primary focus is on developing innovative strategies for earlier detection and more effective treatment of this cancer. They conduct groundbreaking research projects, such as creating a stage I diagnostic test, enhancing the accuracy of a drug predictive algorithm, and developing a nanohydrogel capable of eliminating cancer tumors. The institute also provides educational opportunities for medical professionals, raising awareness about ovarian cancer symptoms and their treatment options among women. With a team of 1 dedicated individual, they strive tirelessly to contribute to the fight against ovarian cancer.


Official website here: www.ovariancancerinstitute.org

What are the reviews and ratings of this charity?

Charity Navigator Rating: 88%, Three-Star out of Four Star rating.

The Ovarian Cancer Institute Inc has received a solid Three-Star rating from Charity Navigator, indicating a commendable level of accountability and financial health. The overall score, which is specifically based on the organization's accountability and finance practices, reflects strong governance structures, with a majority of independent board members and an effective audit committee. The organization scored particularly well in areas such as program expense ratio, demonstrating that a significant portion of its funds is directed towards its mission.

While the organization excels in many aspects of accountability, there are some areas for improvement. Notably, the institute lacks a whistleblower policy and a document retention and destruction policy, which could enhance its governance framework. However, the absence of these policies has not detracted from its overall strong performance, as evidenced by its high scores across other evaluative measures.

In terms of financial management, the Ovarian Cancer Institute also maintains a low liabilities-to-assets ratio and a robust program expense ratio, showcasing its ability to manage resources effectively. With these strengths, the organization stands out as a responsible and impactful entity in the nonprofit sector, although addressing the identified gaps in policy could further strengthen its governance.


This AI summary has been generated from information found on Charity Navigator.

Is The Ovarian Cancer Institute Inc legitimate?

The Ovarian Cancer Institute Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. The Ovarian Cancer Institute Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $160,250
Professional Fundraising Fees: $0
Other Salaries and Wages: $0

For more financial information, click here


Official website here: www.ovariancancerinstitute.org

What is the mission statement of The Ovarian Cancer Institute Inc?

The Ovarian Cancer Institute's mission is centered around three key areas. Firstly, it aims to conduct innovative research to facilitate early detection and more effective treatment of ovarian cancer. Secondly, the institution works towards educating medical professionals and increasing the awareness of ovarian cancer symptoms and treatment options among women. Lastly, it investigates new modes of treatment for this type of cancer. The institute is currently supporting research projects that include developing a stage I diagnostic test for ovarian cancer, enhancing the accuracy of a drug predictive algorithm, and the creation of a nanohydrogel designed to eliminate cancer tumors. In 2022, both the diagnostic test and drug predictive algorithm showed improved accuracy, with the nanohydrogel project progressing towards a first-in-human trial, preparing for potential FDA approval.


Official website here: www.ovariancancerinstitute.org

Who is the CEO of The Ovarian Cancer Institute Inc?

Benedict Benigno is the Ceo of The Ovarian Cancer Institute Inc. The CEO's salary of The Ovarian Cancer Institute Inc is $45,000 and their total compensation is $45,000.


Official website here: www.ovariancancerinstitute.org

What is the revenue of The Ovarian Cancer Institute Inc?

The Ovarian Cancer Institute Inc's revenue in 2022 was $672,275.


Official website here: www.ovariancancerinstitute.org

Who are the executives of The Ovarian Cancer Institute Inc and what are their salaries?

The average compensation at The Ovarian Cancer Institute Inc during 2022 was $160,250. There is 1 employee and 30 volunteers at The Ovarian Cancer Institute Inc.


Here are 16 key members and their salaries (The Ovarian Cancer Institute Inc's CEO's salary is $45,000 and their total compensation is $45,000):


Kathryn Jones (Executive Di)
  • Compensation: $115,250
  • Related: $0
  • Other: $0
Benedict Benigno (Ceo)
  • Compensation: $45,000
  • Related: $0
  • Other: $0
Vicki Barnett (Coo)
  • Compensation: $0
  • Related: $0
  • Other: $0
Dana Whitlow (Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0
Heather Catlin (Vice Chairma)
  • Compensation: $0
  • Related: $0
  • Other: $0
Becca Krumdieck (Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Shannon Banna (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Bob Danville (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Paula Demarini (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jill Jacobs (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Marci Knauss (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Marie Sapota (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Charles Sheron (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Collin Trost (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Richard Zane (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Hillyer Young (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0


Official website here: www.ovariancancerinstitute.org

Where can I find the form 990 for The Ovarian Cancer Institute Inc?

The Ovarian Cancer Institute Inc's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.ovariancancerinstitute.org

Learn more at the official website: www.ovariancancerinstitute.org

Mission Statement of The Ovarian Cancer Institute Inc

The Ovarian Cancer Institute, a dedicated organization, is committed to three primary objectives. Firstly, it aims to spearhead innovative research, leading to earlier detection and more effective control of ovarian cancer. Secondly, the institute strives to educate women about the symptoms of ovarian cancer and the available treatment options, thereby heightening their awareness. Lastly, the institution investigates newer modalities of treatment for ovarian cancer.

In pursuit of its mission, The Ovarian Cancer Institute is currently supporting various research projects. One such project is developing a stage I diagnostic test for ovarian cancer, which has shown promising results in increasing accuracy over 2022. Another project involves improving the accuracy of a drug predictive algorithm, which could significantly impact treatment decisions. Lastly, the institute is working on a nanohydrogel project, which, if successful, could eliminate ovarian cancer tumors. This project is moving towards a first-in-human trial, paving the way for potential FDA approval.

In essence, The Ovarian Cancer Institute's mission is multifaceted, focusing on research, education, and the exploration of new treatment options for ovarian cancer. Through its efforts, the institute seeks to improve outcomes for those affected by this disease and contribute to the broader fight against cancer.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




July, 2024

The Ovarian Cancer Institute Inc is at the forefront of developing innovative research for early detection and more effective treatment of ovarian cancer. Their ongoing support for research projects, such as the development of a stage I diagnostic test, a drug predictive algorithm, and a nanohydrogel to eliminate cancer tumors, showcases their commitment to advancing the field. In 2022, the diagnostic test and drug predictive algorithm saw increased accuracy, demonstrating tangible progress. Additionally, the nanohydrogel project is moving towards a first-in-human trial, a significant step towards potential FDA approval. Through their efforts, The Ovarian Cancer Institute is making a crucial impact in the fight against ovarian cancer, providing hope and solutions for patients and their families.




This information is meant to be a general summary of The Ovarian Cancer Institute Inc. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$672,275 (2022)
Expenses
$913,027 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $16
  • Gross Receipts: $778,248

Assets and Liabilities:

  • Total Assets: $351,433
  • Total Liabilities: $3,800
  • Net Assets: $347,633

Want to help this charity, for free? You can click here to learn more about Give Freely

Organization Details

Founding Year

1999

Principal Officer

Benedict Benigno

Main Address

1266 W PACES FERRY ROAD SUITE 339, ATLANTA, GA, 30327

NTEE Category

Code: G30 - Disease

If you are a representative of The Ovarian Cancer Institute Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.